Pacific Biosciences Of California (PACB) Change in Inventory (2016 - 2025)
Pacific Biosciences Of California has reported Change in Inventory over the past 15 years, most recently at -$3.5 million for Q4 2025.
- Quarterly results put Change in Inventory at -$3.5 million for Q4 2025, up 50.42% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (down 82.94% YoY), and the annual figure for FY2025 was $1.4 million, down 82.94%.
- Change in Inventory for Q4 2025 was -$3.5 million at Pacific Biosciences Of California, down from $1.1 million in the prior quarter.
- Over the last five years, Change in Inventory for PACB hit a ceiling of $13.3 million in Q1 2023 and a floor of -$9.0 million in Q4 2023.
- Median Change in Inventory over the past 5 years was $3.1 million (2023), compared with a mean of $3.7 million.
- Biggest five-year swings in Change in Inventory: skyrocketed 660.88% in 2021 and later plummeted 185.47% in 2023.
- Pacific Biosciences Of California's Change in Inventory stood at $7.7 million in 2021, then surged by 37.66% to $10.5 million in 2022, then plummeted by 185.47% to -$9.0 million in 2023, then rose by 21.47% to -$7.1 million in 2024, then soared by 50.42% to -$3.5 million in 2025.
- The last three reported values for Change in Inventory were -$3.5 million (Q4 2025), $1.1 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.